ReviewDiabetes technology & therapeutics2017
Metrics Beyond Hemoglobin A1C in Diabetes Management: Time in Range, Hypoglycemia, and Other Parameters.
Review in Diabetes technology & therapeutics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05574023 (Impact of Continuous Glucose Monitoring), which is not on this map. Cited by 87 papers, 6 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Impact of Continuous Glucose Monitoring (CGM) With Predictive Alarm for Hypoglycemia (Guardian Connect System) on Glycemic Control and Hypoglycemia Management in a Group of Adolescents With Type 1 Diabetes Mellitus Treated With Multiple Daily Insulin Injections (MDI).
Who cites it
87 citing papers in PubMed, 6 syntheses or guidelines pooled it.
- Effectiveness of continuous glucose monitoring in patient management of Type 2 Diabetes Mellitus: an umbrella review of systematic reviews from 2011 to 2024.Archives of public health = Archives belges de sante publique · 2024Pooled it
- Effect of divergent continuous glucose monitoring technologies on glycaemic control in type 1 diabetes mellitus: A systematic review and meta-analysis of randomised controlled trials.Diabetic medicine : a journal of the British Diabetic Association · 2022Pooled it
- Machine Learning and Smart Devices for Diabetes Management: Systematic Review.Sensors (Basel, Switzerland) · 2022Pooled it
- Efficacy of Flash Glucose Monitoring in Type 1 and Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.Frontiers in clinical diabetes and healthcare · 2022Pooled it
- Efficacy and safety of dual SGLT 1/2 inhibitor sotagliflozin in type 1 diabetes: meta-analysis of randomised controlled trials.BMJ (Clinical research ed.) · 2019Pooled it
- Family-Based Interventions Targeting Improvements in Health and Family Outcomes of Children and Adolescents with Type 1 Diabetes: a Systematic Review.Current diabetes reports · 2018Pooled it
- Efficacy ofDiabetes technology & therapeutics · 2020Trial
- Effect of Aerobic and Resistance Exercise on Glycemic Control in Adults With Type 1 Diabetes.Canadian journal of diabetes · 2019Trial
- Identification of clinically relevant dysglycemia phenotypes based on continuous glucose monitoring data from youth with type 1 diabetes and elevated hemoglobin A1c.Pediatric diabetes · 2019Trial
- Reduced Glucose Variability With Glucose-Dependent Versus Glucose-Independent Therapies Despite Similar Glucose Control and Hypoglycemia Rates in a Randomized, Controlled Study of Older Patients With Type 2 Diabetes Mellitus.Journal of diabetes science and technology · 2018Trial
- Real-world comparative effectiveness of analogue and human insulin on glycemic control in children and adolescents with Type 1 diabetes in Lebanon using continuous glucose monitoring data.Journal of comparative effectiveness research · 2026Article
- The Relationship between Hemoglobin A1c and the Glucose Management Indicator and Glucose Metrics in Children and Adolescents with Type 1 Diabetes Mellitus Using Automated Insulin Delivery SystemsJournal of clinical research in pediatric endocrinology · 2026Observational
- Association of Continuous Glucose Monitoring with Glycaemic, Distress, and Quality of Life Outcomes in Insulin-Treated Type 2 Diabetes: A 12-Month Prospective Study.Medicina (Kaunas, Lithuania) · 2026Observational
- Artificial Intelligence for Blood Glucose Level Prediction in Type 1 Diabetes: Methods, Evaluation, and Emerging Advances.Sensors (Basel, Switzerland) · 2026Review
- Can continuous glucose monitoring-derived glycemic variability predict retinal neurodegeneration earlier than HbA1c in patients without clinically apparent retinopathy?Frontiers in endocrinology · 2026Review
- Revolutionizing diabetes care: the role of artificial intelligence in prevention, diagnosis, and patient care.Journal of diabetes and metabolic disorders · 2025Review
- Psychometric properties of the EQ-5D-5L in diabetes mellitus patients in Spain.Journal of patient-reported outcomes · 2025Article
- National Telehealth Contingency Staffing Program and Primary Care Quality in the VHA.JAMA network open · 2025Article
- Relation of time in range to severity of coronary artery disease in patients with type 2 diabetes: A cross-sectional study.Open medicine (Warsaw, Poland) · 2025Article
- Impact of HbA1c Reduction on Major Kidney Outcomes in Type 2 Diabetes With Poor Glycemic Control and Advanced CKD.International journal of endocrinology · 2025Article
27 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We review clinical instances in which A1C should not be used and reflect on the use of other glucose metrics that can be used, in substitution of or in combination with A1C and SMBG, to tailor an individualized approach that will result in better outcomes and patient empowerment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.